Search

everythinglearnresearchcommunity

for

Search:↓

A new gene mutation causes vitamin D resistance and rickets, treatable with calcium therapy.

Human liver enzyme DHEA ST helps process minoxidil.

New research is needed to create better drugs that block the enzyme responsible for conditions like male baldness and prostate enlargement.

JAK inhibitors are more effective and safer for treating alopecia areata than dupilumab and apremilast.

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

A new compound, 3a, effectively fights prostate cancer better than finasteride.

New drugs targeting the JAK-STAT pathway show promise for treating inflammatory skin diseases.

Dextran sulfate was found to be toxic and ineffective for treating HIV.

JAK-inhibitors for alopecia areata are generally safe with mostly mild side effects and a low rate of treatment withdrawal.

34% of patients on hepatitis C treatment had reversible skin issues.

A new compound may treat benign prostatic hyperplasia better than finasteride.

Adalimumab significantly improves quality of life for patients with moderate to severe hidradenitis suppurativa.

Diphencyprone is effective for treating patchy hair loss in alopecia areata, but tacrolimus is not.

Certain mutations in the H6PD gene cause Cortisone Reductase Deficiency by affecting hormone production.

Pembrolizumab can cause serious liver issues, requiring close monitoring and early treatment.

A dissolving microneedle patch with dutasteride offers effective, long-lasting hair loss treatment with fewer side effects.

Upadacitinib improved multiple immune-related conditions in one patient.

Oral JAK inhibitors show promise for treating alopecia areata but have challenges like relapse and side effects.

Oral minoxidil can help regrow hair lost from antibody-drug conjugate treatment.

No single ideal JAK inhibitor for alopecia areata has been determined; JAK3 inhibitors may be promising with fewer side effects.

Dual-targeting therapies like Janus kinase inhibitors may treat both alopecia areata and other immune diseases.

Baricitinib is effective for severe alopecia areata with manageable side effects, mainly upper respiratory infections.

A new method was created to test the effectiveness of Dihydrotestosterone (DHT) inhibitors, like finasteride and dutasteride, in human and fish cells. The results showed fish cells are more sensitive to these treatments, and dutasteride works better than finasteride in all tested cells.

A new drug, dutasteride, is at least as effective as the older drug, finasteride, for treating enlarged prostate and may have additional uses.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

Baricitinib is effective in promoting hair growth in severe alopecia areata.

Certain genes and high cholesterol levels increase heart disease risk in Ethiopian patients with high blood pressure.

Upadacitinib may effectively treat twenty-nail dystrophy without causing pain.

Allergic reactions to blood thinners are rare but can be serious, requiring careful management and alternative treatments.